F. Bieri
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 6
- Drug-Induced Hepatotoxicity and Protection 4
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 4
- Clinical Biochemistry top 5%
- Hepatology top 10%
-
- Carcinogens and Genotoxicity Assessment 3
- Cancer, Hypoxia, and Metabolism 3
-
- Peroxisome Proliferator-Activated Receptors 13
-
- Drug Transport and Resistance Mechanisms 8
-
- Adipose Tissue and Metabolism 4
- Co-authors
- W. StäubliP. BentleyFelix WaechterSamar F. Muakkassah-KellyF. WaechterMiguel BronfmanEtienne‐Emile BaulieuAriel Orellana
- Partner nations
- SwitzerlandFranceChile
In The Last Decade
F. Bieri
27 papers receiving 551 citations
Peers
Comparison fields: 5 of 76
- Pharmacology 144
- Biochemistry 101
- Clinical Biochemistry 88
- Hepatology 56
- Cancer Research 92
Countries citing papers authored by F. Bieri
This map shows the geographic impact of F. Bieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Bieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Bieri more than expected).
Fields of papers citing papers by F. Bieri
This network shows the impact of papers produced by F. Bieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Bieri. The network helps show where F. Bieri may publish in the future.
Co-authorship network
The 23 scholars most cited alongside F. Bieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 3 | |
| 2 | 1993 | 13 | |
| 3 | 1993 | 8 | |
| 4 | 1991 | 8 | |
| 5 | 1990 | 53 | |
| 6 | 1990 | 7 | |
| 7 | 1990 | 12 | |
| 8 | 1990 | 9 | |
| 9 | 1989 | 27 | |
| 10 | 1989 | 60 | |
| 11 | 1988 | 16 | |
| 12 | 1988 | 11 | |
| 13 | 1988 | 19 | |
| 14 | 1988 | 11 | |
| 15 | 1988 | 14 | |
| 16 | 1987 | 59 | |
| 17 | 1987 | 9 | |
| 18 | 1986 | 5 | |
| 19 | 1984 | 75 | |
| 20 | 1983 | 46 |
About F. Bieri
F. Bieri is a scholar working on Pharmacology, Biochemistry, Cancer Research, Clinical Biochemistry and Oncology, having authored 27 papers that have together received 581 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (13 papers), Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Adipose Tissue and Metabolism (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Pharmacology (144 citations), Biochemistry (101 citations), Clinical Biochemistry (88 citations), Hepatology (56 citations) and Cancer Research (92 citations). F. Bieri has collaborated with scholars based in Switzerland, France and Chile. Frequent co-authors include W. Stäubli, P. Bentley, Felix Waechter, Samar F. Muakkassah-Kelly, F. Waechter, Miguel Bronfman, Etienne‐Emile Baulieu, Ariel Orellana, H. Dariush Fahimi and Alfred Völkl. Their work appears in journals such as Carcinogenesis, Biochemical Pharmacology, Toxicology in Vitro, Experimental Cell Research and Toxicology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.